4//SEC Filing
WP X Finance, L.P. 4
Accession 0000899243-20-012345
CIK 0001397702other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 8:50 PM ET
Size
31.1 KB
Accession
0000899243-20-012345
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2020-05-05$39.00/sh−4,885,078$190,518,042→ 1,021,223 total
WPP GP LLC
10% Owner
Transactions
- Sale
Common Stock
2020-05-05$39.00/sh−4,885,078$190,518,042→ 1,021,223 total
WP X Finance, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-05-05$39.00/sh−4,885,078$190,518,042→ 1,021,223 total
WARBURG PINCUS X PARTNERS, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-05-05$39.00/sh−4,885,078$190,518,042→ 1,021,223 total
Warburg Pincus X, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-05-05$39.00/sh−4,885,078$190,518,042→ 1,021,223 total
Warburg Pincus Partners GP LLC
10% Owner
Transactions
- Sale
Common Stock
2020-05-05$39.00/sh−4,885,078$190,518,042→ 1,021,223 total
WPX GP, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-05-05$39.00/sh−4,885,078$190,518,042→ 1,021,223 total
Warburg Pincus X LLC
10% Owner
Transactions
- Sale
Common Stock
2020-05-05$39.00/sh−4,885,078$190,518,042→ 1,021,223 total
Warburg Pincus Partners, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-05-05$39.00/sh−4,885,078$190,518,042→ 1,021,223 total
Footnotes (5)
- [F1]In connection with the Issuer's public offering, 4,733,641 shares were sold by WP X Finance, L.P. ("WP X Finance"), and 151,437 shares were sold by Warburg Pincus X Partners, L.P. ("WPXP"), each to the underwriters of the public offering.
- [F2]Pursuant to an underwritten public offering of the Issuer's common stock (the "Offering"), on May 5, 2020, the Issuer, WP X Finance, WPXP and the underwriters of the Offering (the "Underwriter"), entered into an Underwriting Agreement (the "Underwriting Agreement"). Pursuant to the Underwriting Agreement, WP X Finance and WPXP sold an aggregate of 4,885,078 shares of common stock of the issuer to the Underwriters. The per share sale price reported in this Form 4 does not reflect underwriting discounts.
- [F3]989,570 of these shares are held by WP X Finance and 31,653 of these shares are held by WPXP.
- [F4]WPX GP, L.P., a Delaware limited partnership ("WPX GP"), is the managing general partner of WP X Finance. Warburg Pincus Private Equity X, L.P., a Delaware limited partnership ("WP X"), is the general partner of WPX GP. Warburg Pincus X, L.P., a Delaware limited partnership ("WPX LP"), is the general partner of WP X and WPXP. Warburg Pincus X GP L.P., a Delaware limited partnership ("WP X GP LP"), is the general partner of WPX LP. WPP GP LLC, a Delaware limited liability company ("WPP GP"), is the general partner of WP X GP LP. Warburg Pincus Partners, L.P., a Delaware limited partnership ("WP Partners"), is the managing member of WPP GP. Warburg Pincus Partners GP LLC, a Delaware limited liability company ("WP Partners GP"), is the general partner of WP Partners.
- [F5](continuation from footnote 4) Warburg Pincus & Co., a New York general partnership ("WP"), is the managing member of WP Partners GP. Warburg Pincus LLC, a New York limited liability company ("WP LLC") is the manager of WP X Finance, WPXP, and WP X.
Issuer
Silk Road Medical Inc
CIK 0001397702
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001770767
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 8:50 PM ET
- Size
- 31.1 KB